David A. Siegel Fortress Biotech, Inc. Transaction History

Two Sigma Advisers, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.65 - $1.1 $1,170 - $1,980	-1,800 Reduced 6.5%	25,900 $21,000
Q3 2022 Nov 14, 2022	SELL	$0.79 - $22.0 $1,027 - $28,600	-1,300 Reduced 4.48%	27,700 $24,000
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $2,240 - $4,200	-2,800 Reduced 8.81%	29,000 $24,000
Q1 2022 May 16, 2022	SELL	$1.24 - $2.75 $8,956 - $19,863	-7,223 Reduced 18.51%	31,800 $43,000
Q4 2021 Feb 14, 2022	SELL	$2.42 - $3.65 $578,864 - $873,080	-239,200 Reduced 85.97%	39,023 $98,000

Q3 2021 Nov 15, 2021	BUY	$2.82 - $3.7 $336,144 - $441,040	119,200 Added 74.96%	278,223 $896,000
Q2 2021 Aug 16, 2021	SELL	$3.5 - $5.48 $366,100 - $573,208	-104,600 Reduced 39.68%	159,023 $568,000
Q1 2021 May 17, 2021	BUY	$3.16 - $4.89 $11,376 - $17,604	3,600 Added 1.38%	263,623 $931,000
Q4 2020 Feb 16, 2021	BUY	$2.2 - $4.45 $73,480 - $148,630	33,400 Added 14.74%	260,023 $824,000
Q3 2020 Nov 16, 2020	BUY	$2.62 - $4.78 $452,736 - $825,984	172,800 Added 321.05%	226,623 $916,000
Q2 2020 Aug 14, 2020	BUY	$1.83 - $3.16 $98,496 - $170,080	53,823 New	53,823 $144,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.